Visual Hallucinations Essay

Parkinson’s disease is a very well-known disease. It plagues about five million people worldwide, about a million of those cases are in the United States. A person does not lower their chances of getting Parkinson’s by living in a certain part of the world. It is not more, likely to happen in one location than, another. It has to do with age and genetics (“Demographics of parkinson’s,” 2014). It is a disease of the older generation, around about one percent of people over the age of 60 years old have Parkinson’s disease (Hauser, 2014). As one ages the likelihood of a person developing goes up. About four percent of people over the age of 80 years old develop Parkinson’s disease. The percentage of people who have Parkinson’s that are younger than 40 years old, is less than 10 percent. It is more

The major component shared by both Parkinson’s disease and dementia is the functioning of neurons, with a then understandable association. Dementia is caused by neuron demise or diminished capacity of communication with other cells, while Parkinson’s disease, neurons in the basal ganglia experience deterioration that disrupts the normal neurotransmitter dopamine balance where neurons waste and die. With this shared neuron deterioration, the prevalence of dementia associated with Parkinson’s disease is clearly understood. One-third of all patients with Parkinson’s disease will display dementia (LeMone, Burke, & Bauldoff, 2011) with indicators identical to Alzheimer’s form of dementia.

Botella et al. (2010) evaluated the efficacy of VR apparatus called Emma’s world. Emma’s world consisted of a large screen projector which included virtual objects, music, sounds, images, colors, videos and texts designed to represent various traumatic events. The control condition included in-vivo and imaginal

Parkinson’s disease, a type of dementia also known as idiopathic or primary parkinsonism, paralysis agitans, or hypokinetic rigid syndrome/HRS, is on the rise in the U.S. Each year there are over 60,000 new cases in the U.S. alone. With the average person diagnosed with Parkinson’s disease over the age of 65 and America’s rapidly growing elderly population, awareness and concern are becoming significant points of interest for many healthcare professionals.

The National Parkinson Foundation located on the website www.parkinson.org, was designed to help people who are affected by parkinson’s disease and to be more aware of the disease through education, treatment options and expert care research. The mission of the non-profit organization states “We make life better for people with Parkinson 's through expert care and research. Everything we do helps people actively enjoy life with their friends, families, children and grandchildren until there is a tomorrow without Parkinson 's” (National Parkinson Foundation). The National Parkinson Foundation targeted audiences includes people who suffer from

Parkinson’s and Alzheimer’s disease are two degenerative brain diseases that differ in their symptoms, causes, treatment, physical and biological indicators. Per Hooley et al. (2017), Parkinson’ disease is thought to be caused by an extended reduction of dopamine, which the absence of constrains normal neural impulses in the brain. After some time, movements such as tremors, stammered speech, diminished or unintentional body movements are demonstrated. Those that suffer from Parkinson’s disease often have an incapability to swallow and muscle stiffness that affects muscles in their faces with mental deterioration occurring as the disease progresses. Parkinson’s disease can be traced to gender and genetics and most of those affected are men that have a family history of the disease (APA, 2013). Treatment for Parkinson’s disease encompasses dopamine precursors to increase the presence of dopamine.

Affecting an estimated 4 million people worldwide (NIH), Parkinson’s is one of the less common nervous system disorders. Despite its rarity, Parkinson’s is largely researched because there is no cure and few effective treatments. It also has a big impact on quality of life for those afflicted. This disease usually shows up after age 40 and occurs when the brain cells that are responsible for motor skills die. Symptoms include tremors, inability to move, and impaired cognitive function, all of which worsen over time. Because this is a condition that affects the brain, if an effective treatment can be established, treatments for other more common conditions such as Alzheimer’s may soon follow. This makes it a critical topic for today’s doctors and scientists.

The main outcome of this Prospective Cohort Study is incidence of dementia in subjects with Parkinson’s disease.

Parkinson’s disease (PD) is the second most common neurodegenerative disorder in the world. Since an increasing number of people are reaching a high age, it is predicted that also the prevalence of Parkinson’s disease will be higher in the future. The symptoms of the disease are both motor symptoms like tremor and impairment of the gait, but along with that, psychological symptoms and memory loss are evident in many cases.

Parkinson Disease’s (PD) is defined as progressive loss of pigmented neurons or cells in the substantia nigra of the brain. These cells manufacture the molecule dopamine, a chemical responsible for regulating purposeful movements. Moreover, when the dopamine level in the brain depletes by 80 percent, the patient will begin experiencing symptoms of PD. Genetics also play a vital role in Parkinson’s development--mutations in the Leucine-Repeat Kinase 2 are its greatest contributors. Furthermore, dopamine levels progressively drop in patients with the disease; therefore, their symptoms gradually become severe as they age. Parkinson’s symptoms are categorized into primary, secondary, motor, and nonmotor. (Fallon & Cataldo, 2013)

Parkinson’s disease is a chronic neurodegenerative disorder characterized by degeneration and cell loss of the substantia nigra, which causes disturbances of voluntary motor control [5]. It impairs ones ability to produce movements and is commonly associated with difficulties of daily living. Parkinson’s disease (PD) affects approximately 1.5% to 2.0% of the population over the age of sixty years old [2] and “… it is estimated that 6 million individuals worldwide are currently living with PD,” [7] (pg323). Parkinson’s sufferers often experience physical distress and an altered quality of life.

This paper is limited to Parkinson’s Disease. Parkinson’s Disease was thoroughly researched and will be described in depth including: physiology, etiology, signs and symptoms, diagnostic testing, therapeutic measures, and short vs. long term effects.

Parkinson’s Disease (PD) is a nervous system disorder that affects nearly five million people world wide. Most of the effects of PD are movement based. It is more prevalent in men and the chance of developing the disease increases with age. Fifteen percent of those with Parkinson’s have been identified as having a family history of the disease. Those who are 80 or older may be one-thousand times more likely to develop PD than those under 40 (Jankovic & Tolosa, 2015). The symptoms of PD were first described in 1817 by James Parkinson. Over time, Parkinson was able to observe the disease in six different patients, seeing the similarities in their symptoms. As sciences have advanced at a rapid rate, the understanding of PD has

About one million Americans and four million people worldwide suffer from Parkinson’s disease. The number of individual’s with Parkinson’s increases by at least sixty thousand per year in America. Although the Parkinson’s disease has been around for thousand of years, it was not officially recognized until 1817 by a Dr. James Parkinson. Dr. James Parkinson clearly stated in his paper An Essay on the Shaking Palsy symptoms of Parkinson’s that are still recognized today as markers for the disease. Even though he wrote that paper in 1817, it was not until 1861 that the medical community began to collectively look into this debilitating disease.

• People aged older than 50 years, both men and women who have been diagnosed with Parkinson’s disease.